CCDC111 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.690500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.143400E-01
Normal-vs-Stage2
9.544600E-03
Normal-vs-Stage3
1.177850E-02
Normal-vs-Stage4
6.000800E-01
Stage1-vs-Stage2
2.040400E-01
Stage1-vs-Stage3
2.875900E-02
Stage1-vs-Stage4
5.673400E-01
Stage2-vs-Stage3
5.729900E-02
Stage2-vs-Stage4
5.721600E-02
Stage3-vs-Stage4
4.277900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.478400E-02
Normal-vs-AfricanAmerican
5.682300E-02
Normal-vs-Asian
1.376410E-02
Caucasian-vs-AfricanAmerican
9.037600E-01
Caucasian-vs-Asian
1.150800E-01
AfricanAmerican-vs-Asian
3.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.788100E-02
Normal-vs-Female
5.908200E-02
Male-vs-Female
1.577960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.832040E-01
Normal-vs-Age(41-60Yrs)
4.587600E-02
Normal-vs-Age(61-80Yrs)
4.685600E-02
Normal-vs-Age(81-100Yrs)
8.560800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.247600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.887200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.603600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.270400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.102600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.241600E-03
Normal-vs-Daily Drinker
4.398900E-03
Normal-vs-Weekly Drinker
1.164220E-02
Normal-vs-Occasional Drinker
2.988000E-01
Normal-vs-Social Drinker
3.941800E-01
Non Drinker-vs-Daily Drinker
6.480000E-01
Non Drinker-vs-Weekly Drinker
6.642200E-01
Non Drinker-vs-Occasional Drinker
1.537630E-01
Non Drinker-vs-Social Drinker
3.364100E-02
Daily Drinker-vs-Weekly Drinker
9.657400E-01
Daily Drinker-vs-Occasional Drinker
1.015580E-01
Daily Drinker-vs-Social Drinker
1.032140E-02
Weekly Drinker-vs-Occasional Drinker
1.414810E-01
Weekly Drinker-vs-Social Drinker
2.920300E-02
Occasional Drinker-vs-Social Drinker
5.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.686980E-01
Normal-vs-Grade 2
4.551800E-02
Normal-vs-Grade 3
7.971700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.524400E-01
Grade 1-vs-Grade 3
5.226800E-01
Grade 1-vs-Grade 4
1.686980E-01
Grade 2-vs-Grade 3
6.733600E-01
Grade 2-vs-Grade 4
4.551800E-02
Grade 3-vs-Grade 4
7.971700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.054000E-02
Normal-vs-NonDiabetic
5.518400E-02
Diabetic-vs-NonDiabetic
2.236000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.728400E-02
Normal-vs-NoPancreatitis
4.695700E-02
Pancreatitis-vs-NoPancreatitis
8.181000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.776990E-01
Normal-vs-N1
1.008460E-02
N0-vs-N1
4.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.334200E-02
Normal-vs-TP53-NonMutant
3.346600E-01
TP53-Mutant-vs-TP53-NonMutant
2.808500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
